Maternal type 1 diabetes causes heart defects.

Published Date: 02 Mar 2023

A review of more than 600,000 Finnish births from 2006 to 2016 found that mothers with type 1 diabetes had more than four times as many children born with heart defects.

Read Full News

Latest News

People Living Together Share More Oral and Gut Microbiota

People with close family ties who live together share more oral and gut microbes with each other than with other people in their communities.

National AI Initiative Promising for Canadian Healthcare

Canada's new national AI strategy, "AI for All," aims to build trust, expand opportunities, and ensure that AI is used responsibly in healthcare and other industries.

Vitamin K2 Supplementation May Curb Coronary Calcification

Supplementation with vitamin K2 may help slow the progression of coronary artery calcification among people with mild coronary artery disease.

Post-Deprescribing, Do Older Adults Get Inappropriate Meds?

When substitutions occur, more than 1 in 4 involve a potentially inappropriate medication.

WHO Urges Europe to Strengthen Preparedness for Extreme Heat

Updated WHO guidance urges clinicians and health systems to identify vulnerable individuals early and strengthen prevention before extreme heat drives illness and death.

How Donors Died May Not Matter for Heart Transplant Outcomes

Recipients of heart transplants have similar 10-year survival and graft health outcomes, regardless of whether hearts are obtained from donors after circulatory death or brain death, a study finds.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Latest News

People with close family ties who live together share more oral and gut microbes with each other than with other people in their communities.

Canada's new national AI strategy, "AI for All," aims to build trust, expand opportunities, and ensure that AI is used responsibly in healthcare and other industries.

Supplementation with vitamin K2 may help slow the progression of coronary artery calcification among people with mild coronary artery disease.

When substitutions occur, more than 1 in 4 involve a potentially inappropriate medication.

Updated WHO guidance urges clinicians and health systems to identify vulnerable individuals early and strengthen prevention before extreme heat drives illness and death.

Recipients of heart transplants have similar 10-year survival and graft health outcomes, regardless of whether hearts are obtained from donors after circulatory death or brain death, a study finds.

News All Time

Why Does the Heart Rarely Develop Cancer?

New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.

Inpatient Rehab Underutilized After Stroke, TBI

Fewer than 1 in 4 patients with stroke and fewer than 1 in 7 with traumatic brain injury are discharged from the hospital to an inpatient rehabilitation facility, new data show.

New Vericiguat Analysis Shows Hidden Benefits in HF

Vericiguat may be beneficial for heart failure with reduced ejection fraction, according to a new study that accounted for mortality events occurring after heart failure hospitalization.

Menopause Age Linked to Higher Hypercholesterolaemia Burden

Women experience a significant increase in hypercholesterolaemia diagnoses and related comorbidities around the menopausal transition compared with men.

Early Treatment Cuts Heart Risk in Hypercholesterolaemia

Early treatment of FH in childhood and adolescence may reduce lifetime cholesterol burden and lower the cardiovascular risk compared to treatment starting later in adulthood.

Metyrapone Reduces BP in Mild Autonomous Cortisol Secretion

Evening metyrapone treatment reduces blood pressure at the supine position and epicardial fat in patients with mild autonomous cortisol secretion.

Ultraprocessed Foods: A Factor in Male Fertility Decline?

Emerging evidence links heavily processed dietary patterns to poor semen quality and hormonal changes that may influence reproductive health.

New Atrial Fibrillation May Speed Kidney Decline in Adults

In working-age adults, new-onset atrial fibrillation is linked to a faster decline in kidney function and a substantially higher risk of experiencing a 30% or greater reduction in kidney function.

Gene Therapy Appears to Be Safe in FA Cardiomyopathy

Intravenous gene therapy delivering the frataxin gene appears safe and is associated with preliminary signs of reduced heart damage in patients with Friedreich ataxia cardiomyopathy.

Glycemic Benefits of Testosterone Therapy Wane After 2 Years

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement after 2 years without ongoing lifestyle modification.

Surgery May Extend Survival in EGFR-Mutated Lung Cancer

Surgical removal of residual tumour during TKI therapy may improve survival in patients with epidermal growth factor receptor-mutated non-small cell lung cancer.

AI's 'Blind Trust' Problem Puts Patients at Risk

Panelists at HLTH Europe 2026 warned that clinicians and patients are increasingly deferring to algorithmic outputs over independent judgment.

Closing the Women's Health Gap With AI and Better Data

From cardiac misdiagnosis to an 8-year wait for endometriosis, experts at HLTH Europe lay out how AI and multimodal data can start closing the gender health gap.

Protein and Creatine Supplements Are No Longer Niche

The fitness supplements have gone mainstream. How much is too much? How should GLP-1 patients use them? Will creatine save our brains? Here’s what the science says.

GLP-1s Tied to Higher Risk for Dizziness, Fainting for Some

Hypotension-related events increased after starting GLP-1s in patients taking multiple antihypertensive medications.

Phase 3 HCM Drug Offers Promising Results in Exercise Tests

Treatment with aficamten may improve multiple measures of exercise in patients with obstructive hypertrophic cardiomyopathy, a study finds.

Recommended News For You

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.

Chemotherapy Boosts Survival for Older Patients With TNBC

Cancer Patients' Depression May Be Helped by Psilocybin.

Recommended Articles For You

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring 

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities 

Unlocking the Potential of Palbociclib: A Comprehensive Overview 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

2.

Cancer mortality continuing to decline, says report

3.

Schizophrenia patients are motivated by music therapy.

4.

Infection Burden High With Myeloma T-Cell Therapies

5.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

1.

The Benefits and Risks of Thrombolytics: A Comprehensive Guide 

2.

Strategic Developments in Hematology and Quality Improvement

3.

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment

4.

KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer

5.

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

2.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

3.

Navigating the Complexities of Ph Negative ALL - Part VIII

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

5.

Oropharyngeal Cancer in Relation to HPV Status

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot